Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

A new, quick method detects minoxidil using silver nanoparticles.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Minoxidil's crystal structure shows two different molecule shapes and nitrogen states.

A new, quick method accurately detects minoxidil in drugs and cosmetics.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

A PEG-400/oleic acid mixture best improves drug delivery monitoring through hair follicles.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

DPCP is effective for treating severe alopecia areata, but relapse is common.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

A new compound was made that might help treat diseases related to male hormones.